XML 118 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Cash, cash equivalents, short-term investments and restricted cash
12 Months Ended
Dec. 31, 2019
Cash and Cash Equivalents [Abstract]  
Cash, cash equivalents, short-term investments and restricted cash Cash, cash equivalents, short-term investments and restricted cash 
The following table summarizes the Company’s cash, cash equivalents, short-term investments, and restricted cash at December 31, 2019 and 2018 (in thousands): 
 
December 31, 2019
 
December 31, 2018
Cash and cash equivalents:
 
 
 
Cash
$
70,467

 
58,185

Cash equivalents

 

Cash and cash equivalents
$
70,467

 
$
58,185

Short-term investments
$
7,638

 
$
7,481

Restricted cash
$
10,972

 
$
11,053


 
December 31, 2019
 
December 31, 2018
Cash and cash equivalents
$
70,467

 
$
58,185

Restricted cash
10,972

 
11,053

Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows
$
81,439

 
$
69,238


The following table summarizes the Company’s unrealized gains and losses related to the short-term investments in marketable securities designated as available-for-sale (in thousands): 
 
As of December 31, 2019
 
As of December 31, 2018
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Loss
 
Fair Value
 
Amortized Cost
 
Gross Unrealized Gains
 
Gross Unrealized Loss
 
Fair Value
Marketable securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
7,638

 

 

 
7,638

 
7,481

 

 

 
7,481

Total
$
7,638

 
$

 
$

 
$
7,638

 
$
7,481

 
$

 
$

 
$
7,481

Reported as:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short-term investments
7,638

 

 

 
7,638

 
7,481

 

 

 
7,481

Total
$
7,638

 
$

 
$

 
$
7,638

 
$
7,481

 
$

 
$

 
$
7,481

 
As of December 31, 2019 and 2018, maturities of marketable securities were as follows (in thousands): 
 
December 31, 2019
 
December 31, 2018
Less than 1 year
$
7,638

 
$
7,481

Due in 1 to 2 years

 

Due in 3 to 5 years

 

Total
$
7,638

 
$
7,481


Realized gains and losses on the sale of marketable securities during the years ended December 31, 2019, 2018 and 2017 were immaterial. The Company did not recognize any impairment losses on its marketable securities during the years ended December 31, 2019, 2018 or 2017. As of December 31, 2019, the Company did not have any investments in marketable securities that were in an unrealized loss position for a period in excess of 12 months.